Neuroendocrine cancer hereditary
Psychosocial Aspects of Living with Neuroendocrine Cancer: Patient/Caregiver Panel
Plagiatul — în actualitate Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [ Risk factors.
- Maftei, Doina Azoicai: Cercetari pentru evaluarea unor elemente de orientare a diagnosticului?
- This type of cancer has a high mortality, and the overall survival is also low.
- Unique perspectives from a team of trusted, world-renowned experts ensure this medical reference book remains the most highly-regarded text in the field.
- Teste Archive - Personal Genetics
Breast cancer BC has been recognized to be the most common type of cancer in women all over the world. One of the most aggressive subtype of BC is the triple negative breast cancer TNBC which is defined by the absence of estrogen receptor ER and progesterone neuroendocrine cancer hereditary PR as well as the lack of overexpression of the human epidermal growth factor 2 HER 2.
- Cancerul pancreatic
- Dr Dana Lucia Stanculeanu, MD, pHD - Institute of Oncology Bucharest Romania | PubFacts
As the estrogen and progesterone receptors as well as the expression of HER2 are lacking, a targeted therapy with anti-hormone agents and anti-HER2 cannot be utilized, the therapeutic possibilities for TNBC women are limited. The aim of this review is to present the current scientific data as well as the latest research in TNBC with focus on the risk neuroendocrine cancer hereditary as well as the current role of platinum-based chemotherapeutic agents and their future implications in TNBC treatment.
Information about the neuroendocrine cancer hereditary factors associated to TNBC as well as the chemotherapeutic regimens was searched through Pubmed and Medline using controlled vocabulary e. Systematic reviews, randomized and controlled clinical trials were analyzed.
Archives - Page 8 | The Medical-Surgical Journal
No restrictions regarding date or language were used. TNBC is a complex and heterogeneous neuroendocrine cancer hereditary, divided into many subtypes and neuroendocrine cancer hereditary an aggressive evolution.
More research is required in order to confirm the association between obesity, BMI, parity, use of oral contraceptives, alcohol and cigarette smoking and TNBC. Tumor-based measures of genomic instability will help to clarify the optimal use and activity of platinum in TNBC. However, it is clear than more epidemiological neuroendocrine cancer hereditary as well as neuroendocrine cancer hereditary discovery of novel therapeutic possibilities are mandatory in order to unravel the complexity of this BC subtype, hence offering a chance to women diagnosed with TNBC.
Keywords: breast cancer, triple negative, platinum, neoadjuvant Full text PDF.